Skip to main content
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.5179
-0.0010 (-0.19%)
At close: Nov 13, 2026, 4:00 PM EST
0.4861
-0.0318 (-6.14%)
After-hours: Nov 13, 2026, 7:33 PM EST

SXTP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.211.410.680.250.516.35
Revenue Growth
23.41%106.81%168.70%-50.40%-91.95%149.18%
Gross Profit
-2.06-1.48-4.69-0.41-0.45-0.01
Operating Income
-8.61-7.76-9.72-5.15-1.75-1.12
Net Income
-8.62-7.87-8.43-3.99-6.18-4.25
Earnings Per Share
-5.41-11.74-74.17-240.45--0.23
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.022.753.392.140.260.12
Total Debt
0.150.150.160.1722.6118.8
Net Cash (Debt)
0.872.63.231.97-22.35-18.69
Net Cash Growth
-51.93%-19.61%64.07%---
Net Cash Per Share
0.553.8828.43118.81--0.99

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.77-6.85-5.65-4.54-1.01-0.65
Capital Expenditures
-0.12-0.14-0.1-0.06--0
Free Cash Flow
-8.89-6.99-5.75-4.6-1.01-0.65
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-169.87%-104.94%--163.01%-87.39%-0.14%
Operating Margin
-708.47%-550.61%-1425.88%-2032.78%-342.41%-17.69%
Pretax Margin
-667.68%-522.91%-1167.64%-1503.93%-1208.37%-67.05%
Profit Margin
-709.87%-558.25%-1237.32%-1572.10%-1209.23%-66.93%
FCF Margin
-732.12%-495.99%-844.19%-1814.28%-197.57%-10.27%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.501.534.3523.33--